Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Robert A. Berman | CEO & Director | 760.62k | -- | 1963 |
| Mr. Craig Thomas Glynn | CFO, Treasurer & Secretary | 302.23k | -- | 1961 |
| Dr. Hamed Alavi Ph.D. | Senior VP & Chief Technology Officer | 371.7k | -- | 1984 |
| Dr. Marc H. Glickman M.D. | Senior VP & Chief Medical Officer | 476.38k | -- | 1949 |
| Mr. Warren Hancock | Co-founder | -- | -- | -- |
| Ms. Sandy Prietto | Vice President of Marketing | -- | -- | -- |
| Dr. Benedict Broennimann M.D. | Chief Medical Officer of Outside of United States | 240k | -- | 1957 |
| Mr. Andrew Cormack | Chief Commercial Officer | -- | -- | -- |
enVVeno Medical Corporation
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 37
Description
enVVeno Medical Corporation, a clinical-stage medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease. The company's lead product is the VenoValve, a replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh. The company also develops enVVe, a non-surgical and transcatheter-based replacement venous valve system consisting of the enVVe valve, enVVe delivery system, and delivery system accessories. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.
Corporate Governance
Upcoming Events
May 6, 2025 at 8:00 PM UTC - May 12, 2025 at 8:00 PM UTC
enVVeno Medical Corporation Earnings Date
Recent Events
March 14, 2025 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission